Udit K. Basak

Kolkata, WB 700091, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Journal: Apoptosis : an international journal on programmed cell death
Published: April 06, 2026

The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting.

The Role of Nuclear Factor-κB in Cancer Immunity and Immunoediting.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: December 13, 2025

Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment.

Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: September 24, 2025

Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.

Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.

Journal: Frontiers in immunology
Published: June 27, 2025

In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma.

In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma.

Journal: Scientific reports
Published: November 06, 2024

hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells.

hsa-miR-5688 inhibits FOXC1-OCT4/SOX2 feedforward loop that drives chemoresistance in breast cancer stem cells.

Journal: Molecular therapy. Oncology
Published: September 28, 2024

Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3.

Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3.

Journal: Cellular immunology
Published: July 24, 2024

Tumor-associated macrophages: an effective player of the tumor microenvironment.

Tumor-associated macrophages: an effective player of the tumor microenvironment.

Journal: Frontiers in immunology
Published: September 15, 2023

Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.

Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.

Journal: Discover oncology
Published: May 28, 2023

FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.

FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.

Journal: Frontiers in immunology
Published: July 13, 2021

SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin.

SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin.

Journal: Science signaling
Published: October 21, 2020

Pyridoxine enhances chemo-responsiveness of breast cancer stem cells via redox reconditioning.

Pyridoxine enhances chemo-responsiveness of breast cancer stem cells via redox reconditioning.

Journal: Free radical biology & medicine
Published: February 15, 2020
Showing 1-12 of 14

Last Updated: 09/26/2026